Abstract
There is recent evidence that in addition to the classic JAK/STAT pathways, mitogen-activated proteins (MAP) kinase pathways play important roles in Type I interferon signaling and the generation of interferon responses. In particular, the p38 MAP kinase cascade exerts positive regulatory roles on transciptional activation of interferon-sensitive genes (ISGs) and the induction of the antiproliferative and antiviral properties of interferons. In this chapter, methodologies to detect activation of p38 and various upstream and downstream effectors are provided. Also, the methodological approaches used to examine the role of this pathway on the regulation of hematopoiesis are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E. (1987) Interferons and their actions. Annu. Rev. Biochem. 56, 727–777.
Verma, A., Deb, D. K., Sassano, A., Uddin, S., Varga, J., Wickrema, A., and Platanias, L. C. (2002) Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J. Biol. Chem. 277, 7726–7735.
Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264, 1415–1421.
Platanias, L. C. and Fish, E. N. (1999) Signaling pathways activated by interferons. Exp. Hematol. 27, 1583–1592.
Darnell, J. E., Jr. (1997) Stats and gene regulation. Science. 277, 1630–1635.
Darnell, J. E., Jr. (1998) Studies of IFN-induced transcriptional activation uncover the Jak-Stat pathway. J. Interf. Cyt. Res. 18, 549–554.
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., and Screiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264.
Parmar, S. and Platanias, L. C. (2003) Interferons. Mechanisms of action and clinical applications. Curr. Opin. Oncol. 15, 431–439.
Ahmad, S., Alsayed, Y. M., Druker, B. J., and Platanias, L. C. (1997) The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272, 29991–29994.
Alsayed, Y., Uddin, S., Ahmad, S., Majchrzak, B., Druker, B. J., Fish, E. N., and Platanias, L. C. (2000) IFN-gamma activates the C3G/Rap1 signaling pathway. J. Immunol. 164, 1800–1806.
Fish, E. N., Uddin, S., Korkmaz, M., Majchrzak, B., Druker. B. J., and Platanias, L. C. (1999) Activation of a CrkL-Stat5 signaling complex by type I interferons. J. Biol. Chem. 274, 571–573.
Uddin, S., Yenush, L., Sun, X-J, Sweet, M. E., White, M. F., and Platanias, L. C. (1995) Interferon a engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem. 270, 15938–15941.
Platanias, L. C., Uddin, S., Yetter, A., Sun, X-J., and White, M. F.(1996) The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J. Biol. Chem. 271, 278–282.
Uddin, S., Fish, E. N., Sher, D., Gardziola, C., Colamonici, O. R., Kellum, M., et al. (1997) The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or IFNa receptors. Blood. 90, 2574–2582.
Uddin, S., Fish, E. N., Sher, D. A., Gardziola, C., White, M. F., and Platanias, L. C. (1997) Activation of the phosphatidylinositol 3′-kinase serine kinase by IFNa. J. Immunol. 158, 2390–2397.
David, M., Petricoin, E., 3rd, Benjamin, C., Pine, R., Weber, M. J., and Larner, A. C. (1995) Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins. Science. 269, 1721–1723.
Uddin, S., Mazchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y., Pine, R., et al. (1999) Activation of the p38 map kinase by Type I IFNs. J. Biol. Chem. 274, 30127–30131.
Uddin, S., Lekmine, F., Sharma, N., Majchrzak, B., Mayer, I., Young, P. R., et al. (2000) The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275, 27634–27640.
Mayer, I. A., Verma, A., Grumbach, I. M., Uddin, S., Lekmine, F., Ravandi, F., et al. (2001) The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J. Biol. Chem. 276, 28570–28577.
Li, Y., Sassano, A., Majchrzak, B., Deb, D. K., Levy, D. E., Gaestel, M., et al. (2004) Role of p38 alfa Map kinase in type I interferon signaling. J. Biol. Chem. 279, 970–979.
Tong, L., Pav, S., White, D. M., Rogers, S., Crane, K. M., Cywin, C. L., et al. (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4, 311–316.
Kumar, S., McDonnell, P. C., Gum, R. J., Hand, A. T., Lee, J. C., and Young, P. R. (1997) Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235, 533–538.
Platanias, L.C. (2003) The p38 Map kinase pathway and its role in interferon signaling. Pharmacol. Ther. 98, 129–142.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Sassano, A., Verma, A., Platanias, L.C. (2005). Mitogen-Activated Protein Kinase Pathways in Interferon Signaling. In: Carr, D.J.J. (eds) Interferon Methods and Protocols. Methods in Molecular Medicine™, vol 116. Humana Press. https://doi.org/10.1385/1-59259-939-7:135
Download citation
DOI: https://doi.org/10.1385/1-59259-939-7:135
Publisher Name: Humana Press
Print ISBN: 978-1-58829-418-0
Online ISBN: 978-1-59259-939-4
eBook Packages: Springer Protocols